↓ Skip to main content

Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?

Overview of attention for article published in Alzheimer's Research & Therapy, September 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?
Published in
Alzheimer's Research & Therapy, September 2014
DOI 10.1186/s13195-014-0061-6
Pubmed ID
Authors

Elizabeth Head, Frederick A Schmitt

Abstract

Adults with Down syndrome develop Alzheimer's disease neuropathology in an age-dependent manner. This unique feature provides an opportunity to test interventions targeted for prevention of Alzheimer's disease neuropathology and dementia in Down syndrome.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 17%
Student > Ph. D. Student 4 13%
Other 3 10%
Student > Bachelor 3 10%
Student > Postgraduate 3 10%
Other 7 23%
Unknown 5 17%
Readers by discipline Count As %
Medicine and Dentistry 7 23%
Psychology 7 23%
Biochemistry, Genetics and Molecular Biology 2 7%
Agricultural and Biological Sciences 2 7%
Neuroscience 2 7%
Other 3 10%
Unknown 7 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2014.
All research outputs
#15,305,567
of 22,763,032 outputs
Outputs from Alzheimer's Research & Therapy
#1,107
of 1,211 outputs
Outputs of similar age
#141,115
of 243,384 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#7
of 11 outputs
Altmetric has tracked 22,763,032 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,211 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.2. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,384 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.